Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
Recruiting · NCT06486779 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study | Relapsing Multiple Sclerosis (RMS) | Recruiting | Not stated | 2026-06-11 | NCT06486779 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||